FDA issued a Warning Letter to Samson Pharmaceuticals, Inc. on 12/13/2018 as a result of this inspection.
FDA investigators audited the Samson Pharmaceuticals - Commerce, CA, United States facility and issued inspectional observations (via FDA 483) on 09 Feb 2018.
Add To Cart
- Category: Human Drugs
- Inspection end: 09 Feb 2018
- Location: Commerce, United States
- FEI: 3005644727